FinanceQuartzabout 2 hours ago
TRex Bio IPO Prices at Floor of Range
2 min read
TRex Bio Inc. raised $116.7 million in a U.S. IPO, pricing shares at $14 each, the low end of its $14-to-$16 range. The company sold about 8.3 million shares. It plans to use proceeds for drug candidate TRB-061 trials in mid-2027. The firm recorded a net loss of $34.8 million in 2025.
Level
Hype check
Tap to vote and see what everyone thinks.
